Altimmune, Inc. (ALT)
4.225
-0.02
(-0.35%)
USD |
NASDAQ |
Jan 20, 16:00
4.21
-0.02
(-0.36%)
After-Hours: 20:00
Altimmune Market Cap: 440.85M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Viking Therapeutics, Inc. | 3.789B |
| CorMedix, Inc. | 542.07M |
| Actinium Pharmaceuticals, Inc. | 39.93M |
| Aldeyra Therapeutics, Inc. | 285.77M |
| Seres Therapeutics, Inc. | 131.84M |
Market Cap Related Metrics
| PS Ratio | 16778.75 |
| Price to Book Value | 2.375 |
| Price | 4.225 |
| Earnings Yield | -25.30% |